Spontaneous glycan reattachment following N-glycanase treatment of influenza and HIV vaccine antigens.
Spontaneous glycan reattachment following N-glycanase treatment of influenza and HIV vaccine antigens.
复制标题
DOI:
10.1021/acs.jproteome.9b00620
复制
发表时间:
2020-01
影响因子:
4.4
通讯作者:
Celina Keating;E. Kuhn;Julia Bals;A. Cocco;A. Yousif;C. Matysiak;Maya Sangesland;Larance Ronsard;Matthew Smoot;Thalia Bracamonte Moreno;Vintus Okonkwo;Ian Setliff;I. Georgiev;A. Balazs;S. Carr;D. Lingwood
中科院分区:
文献类型:
--
作者:
Celina Keating;E. Kuhn;Julia Bals;A. Cocco;A. Yousif;C. Matysiak;Maya Sangesland;Larance Ronsard;Matthew Smoot;Thalia Bracamonte Moreno;Vintus Okonkwo;Ian Setliff;I. Georgiev;A. Balazs;S. Carr;D. Lingwood
In cells asparagine/N-linked glycans are added to glycoproteins co-translationally, in an attachment process that is thought to be supported by the folding of the nascent polypeptide sequence. We find that following pruning of N-glycan by the amidase PNGase F, the principle influenza vaccine antigen and major viral spike protein hemagglutinin (HA), spontaneously re-attached N-glycan to its de-N-glycosylated positions when the amidase was removed from solution. This reaction, which we term N-glycanation, was confirmed by site-specific analysis of HA glycoforms by mass spectrometry prior to PNGase F exposure, during exposure to PNGase F, and after amidase removal. Iterative rounds of de-N-glycosylation followed by N-glycanation could be repeated at least 3 times, and was observed for other viral glycoproteins/vaccine antigens, including the envelope glycoprotein (Env) from HIV. Covalent N-glycan reattachment was non-enzymatic as it occurred in the presence of metal ions that inhibit PNGase F activity. Rather, N-glycanation relied on a non-covalent assembly between protein and glycan, formed in the presence of the amidase, where linearization of the glycoprotein prevented this retention and subsequent N-glycanation. This reaction suggests that under certain experimental conditions, some glycoproteins can organize self-glycan addition and highlights a remarkable self-assembly principle that may prove useful for re-engineering therapeutic glycoproteins such as influenza HA or HIV Env, where glycan sequence and structure can markedly affect bioactivity and vaccine efficacy.